Mutations in the adenomatous polyposis coli (APC) gene are known to occur in approximately 60% of all CRC patients [32] and result in activation of β-catenin/Tcf4 which in turn activates cyclin D1 [30]. Here, TCF4 is linked to colorectal carcinoma.